<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Julia Chen</submitter><species>Homo sapiens (human)</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-BSST3074</full_dataset_link><repository>biostudies-other</repository><pubmed_authors>Ewan Millar</pubmed_authors><pubmed_authors>Elgene Lim</pubmed_authors><pubmed_authors>Julia Chen</pubmed_authors><pubmed_authors>Hanyun Zhang</pubmed_authors><pubmed_authors>Sunny Z Wu</pubmed_authors><pubmed_authors>Lois H Browne</pubmed_authors><pubmed_authors>Iveta Slapetova</pubmed_authors><pubmed_authors>Alexander Swarbrick</pubmed_authors><pubmed_authors>Jodi Lynch</pubmed_authors><pubmed_authors>Travis Ruan</pubmed_authors><pubmed_authors>Peter H Graham</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stromal cell subsets modulate T-cell infiltration in early breast cancer</name><description>Recent studies of the tumour microenvironment have elucidated the heterogeneity of stromal cells, with increasing evidence suggesting that stromal subsets play an important role in regulating anti-tumour immunity in breast cancer. However, the functional diversity of these cells within the tumour immune microenvironment and how they interact with immune cells in a spatial and clinical context remain poorly understood. We performed multiplex immunofluorescence on tumour microarrays from two cohorts consisting of 591 breast cancer patients to assess the abundance and spatial co-localisation of stromal and immune subsets and their correlation with clinicopathological features and patient outcomes. We found that stromal cells were spatially distinct. A perivascular-like subset that was dissemi</description><dates><release>2026-06-08T00:00:00Z</release><modification>2026-09-06T04:20:34.205Z</modification><creation>2026-06-03T05:21:39.163Z</creation></dates><accession>S-BSST3074</accession><cross_references/></HashMap>